The emerging role of mass spectrometry-based proteomics in drug discovery

F Meissner, J Geddes-McAlister, M Mann… - Nature Reviews Drug …, 2022 - nature.com
Proteins are the main targets of most drugs; however, system-wide methods to monitor
protein activity and function are still underused in drug discovery. Novel biochemical …

The critical role of Akt in cardiovascular function

P Abeyrathna, Y Su - Vascular pharmacology, 2015 - Elsevier
Akt kinase, a member of AGC kinases, is important in many cellular functions including
proliferation, migration, cell growth and metabolism. There are three known Akt isoforms …

Catalytic in vivo protein knockdown by small-molecule PROTACs

DP Bondeson, A Mares, IED Smith, E Ko… - Nature chemical …, 2015 - nature.com
The current predominant therapeutic paradigm is based on maximizing drug-receptor
occupancy to achieve clinical benefit. This strategy, however, generally requires excessive …

[HTML][HTML] Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans

SH Smith, C Jayawickreme, DJ Rickard… - Journal of Investigative …, 2017 - Elsevier
Tapinarof (GSK2894512) is a naturally derived topical treatment with demonstrated efficacy
for patients with psoriasis and atopic dermatitis, although the biologic target and mechanism …

The Concise Guide to PHARMACOLOGY 2013/14: G protein‐coupled receptors

SPH Alexander, HE Benson… - British journal of …, 2013 - Wiley Online Library
Abstract The Concise Guide to PHARMACOLOGY 2013/14 provides concise overviews of
the key properties of over 2000 human drug targets with their pharmacology, plus links to an …

Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase

T Paquet, C Le Manach, DG Cabrera… - Science translational …, 2017 - science.org
As part of the global effort toward malaria eradication, phenotypic whole-cell screening
revealed the 2-aminopyridine class of small molecules as a good starting point to develop …

[HTML][HTML] PI3K inhibitors in inflammation, autoimmunity and cancer

AK Stark, S Sriskantharajah, EM Hessel… - Current opinion in …, 2015 - Elsevier
Highlights•Preclinical studies support us of PI3K inhibitors in autoimmunity and
inflammation.•First in class PI3K inhibitor has been approved for treatment of B cell …

Recent advances in PI3K/PKB/mTOR inhibitors as new anticancer agents

MA Occhiuzzi, G Lico, G Ioele, M De Luca… - European Journal of …, 2023 - Elsevier
The biochemical role of the PI3K/PKB/mTOR signalling pathway in cell-cycle regulation is
now well known. During the onset and development of different forms of cancer it becomes …

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

P Ciceri, S Müller, A O'mahony, O Fedorov… - Nature chemical …, 2014 - nature.com
Concomitant inhibition of multiple cancer-driving kinases is an established strategy to
improve the durability of clinical responses to targeted therapies. The difficulty of discovering …

A next-generation risk assessment case study for coumarin in cosmetic products

MT Baltazar, S Cable, PL Carmichael… - Toxicological …, 2020 - academic.oup.com
Abstract Next-Generation Risk Assessment is defined as an exposure-led, hypothesis-driven
risk assessment approach that integrates new approach methodologies (NAMs) to assure …